World

Pause in AstraZeneca-Oxford vaccine trial not a setback: UK

Reuters London | Updated on September 09, 2020

Health Secretary Matt Hancock says move won’t impact covid vaccine efforts

Britain’s Health Secretary Matt Hancock said on Wednesday that AstraZeneca’s decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine.

AstraZeneca said it had paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant. “It is obviously a challenge to this particular vaccine trial,” Hancock said on Sky News when asked about the pause in the trial. “It’s not actually the first time this has happened to the Oxford vaccine.” Asked whether it would set back the vaccine development process, he said: “Not necessarily, it depends on what they find when they do the investigation.”

 

Read also: AstraZeneca-Oxford University Covid-19 vaccine trial “on pause”

 

Published on September 09, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like